Constraints | |
Absent trials | 30% |
One-target trials | 45% |
Two-target trials | 25% |
Categorical targets | 20% |
Specific targets | 80% |
Resulting trial distribution | |
Absent | 30% |
One specific target | 36% |
One categorical target | 9% |
Two specific targets | 16% |
Two categorical targets | 1% |
One of each | 8% |
Total | 100% |